Abstract Virological confirmation of varicella zoster virus (VZV) vasculopathy is provided by presence of virus in the cerebral arteries, frequently associated with inflammation. Yet, cerebral arteries from normal subjects have never been studied for VZV DNA or antigen. We analyzed 63 human cerebral arteries from 45 subjects for VZV DNA and antigen, control herpes simplex virus (HSV)-1 DNA and antigen, and leukocyte-specific CD45 antigen. No cerebral arteries contained VZV or HSV-1 DNA or antigen; eight arteries from seven subjects contained leukocytes expressing CD45. Thus, the presence of VZV antigen in cerebral arteries of patients with stroke is likely to be clinically significant.
Introduction
Varicella zoster virus (VZV) vasculopathy is caused by productive virus infection in the cerebral arteries (Doyle et al. 1983; Eidelberg et al. 1986; Fukumoto et al. 1986; Gilden et al. 1996; Berger et al. 2000) where accumulation of myofibroblasts in the arterial intima and loss of smooth muscle cells result in ischemic or hemorrhagic stroke (Nagel et al. 2011 ). In addition, inflammatory cells associated with viral antigen appear to be important in vascular wall changes (Nagel et al. 2013) . However, no systematic investigation has been conducted to determine the frequency of VZV DNA or antigen and leukocytes in cerebral arteries from normal subjects. Herein, we analyzed 63 human cerebral arteries from 45 subjects with no history of transient ischemic attacks or stroke for the presence of VZV DNA and antigen, control HSV-1 DNA and antigen, and leukocyte-specific CD45 antigen.
Materials and methods
All arteries obtained at autopsy were de-identified and deemed exempt by the Colorado Multiple Institutional Review Board. Table 1 provides clinical information on all subjects whose arteries were studied, the postmortem interval and the specific artery analyzed. All arteries were obtained within 48 h after death. The 45 subjects consisted of 30 (67 %) men and 15 (33 %) women with a mean age of 49 years and median age of 51 years (range, 16-89 years) . Multiple branches of arteries comprising the circle of Willis were obtained from subjects 10, 21, 22, 23, and 24; only one artery (middle cerebral) was obtained from each of the remaining 40 subjects. Of the 63 cerebral arteries analyzed, 3 (5 %) were anterior, 47 (75 %) were middle, 6 (10 %) were posterior, 2 (3 %) were basilar, 4 (6 %) were vertebral, and 1 (2 %) was from the vertebrobasilar junction. Cerebral arteries were cut into 10-mm pieces, rinsed in phosphate-buffered saline (PBS), and cut further into two 5-mm pieces for PCR and immunohistochemical (IHC) analysis, respectively. DNA extracted from one 5-mm piece was analyzed by quantitative PCR for the presence of VZV DNA using VZV-specific primers (forward 5′ -CGAACACGTTCCCCATCAA-3′; reverse 5′-CCCGG CTTTGTTAGTTTTGG-3′ and probe/56-FAM/TCCA GGTTTTAGTTGATACCA/3BHQ_1/) and for HSV-1 DNA using HSV-1-specific primers (forward 5′-TGGTAT TGCCCAACACTTTCC-3′; reverse 5′-GCGCCAGGCA CACACAT -3′ and probe/56-FAM/CGTGTCGCG TGTGGT/3BHQ_1/) and glyceraldehyde-3-phosphate dehydrogenase (GAPdH)-specific primers (forward 5′-CACATGGCCTCCAAGGAGTAA-3′ ; reverse 5′ -TGAGGGTCTCTGTCTTCCTCT -3′ and probe /5HEX/ CTGGACCACCAGCCCCAGCAAG/3IABLFQ/) (Cohrs and Gilden 2007) . Positive and negative controls were provided, respectively, by amplification of serial dilutions of known quantities of VZV DNA and by omission of VZV DNA from the PCR reaction.
The other 5-mm piece of each artery was formalinfixed and paraffin-embedded (FFPE), sectioned at 5 μm, and baked on non-adhesive, positively charged glass slides for 15 min at 65°C. Sections were deparaffinized in 100 % xylene (three times for 5 min each time) followed by 100 % ethanol (three times for 5 min each time). After sequential dipping in 95, 70, and 50 % ethanol, four consecutive sections from each artery were placed in distilled water, blocked in PBS containing 5 % normal rabbit serum (NRS) for 1 h, washed three times with PBS, and incubated for 2 h at room temperature with one of the following primary antibodies: (a) 1:1,000 dilution of primary rabbit polyclonal anti-VZV 63 antibody (Debrus et al. 1995) , (b) 1:1,000 dilution of rabbit anti-HSV-1 antibody (Dako, Carpinteria, CA), (c) 1:1,000 dilution of rabbit polyclonal anti-CD45 antibody (Abcam, Cambridge, MA), or (d) NRS. Positive controls for the two antiviral antibodies were provided by cadaveric cerebral arteries infected ex vivo with VZV or HSV-1, respectively, and prepared as FFPE specimens 14 days post-infection. Positive control for CD45 expression was provided by human tonsil obtained at autopsy and processed as for arteries. After incubation with primary antibody, sections were rinsed three times with PBS and incubated for 1 h with 1:1,000 dilution of biotinylated goat anti-rabbit antibody (Dako) for sections. Sections were then rinsed three times in PBS and incubated with prediluted alkaline phosphataseconjugated streptavidin (Becton-Dickinson, Franklin Lakes, NJ) for 1 h. The color reaction was developed for 2 min using the fresh fuchsin substrate system (Dako) in the presence of levamisole (Dako) at a final concentration 24 μg/ml. The presence of VZV, HSV-1, or CD45 antigen (pink staining) was determined using light microscopy.
Results
PCR analysis of DNA extracted from all 63 arteries revealed the presence of cellular GAPdH, but not VZV or HSV-1 DNA. IHC analysis (Fig. 1 ) demonstrated VZV antigen (A and F, arrows) and HSV-1 antigen (C and H, arrows) in cadaveric infected cerebral artery explant cultures, but not in any of 63 human cerebral arteries (B, D, G, I show representative cerebral arteries from subject 24). No staining was seen in any human cerebral arteries using NRS (E, J). IHC analysis for CD45+ cells (Fig. 2) in cerebral arteries revealed positive staining in control normal human tonsil (a, arrows) and in eight arteries from seven subjects (b shows representative artery from subject 2), and no staining with NRS (c). The seven subjects whose cerebral arteries contained CD45 antigen comprised five men and two women with mean age = 58 years, median age = 55 years, and range 44-89 years.
Of these seven subjects, three died by suicide, one from abdominal hemorrhage, one from cardiac arrest, one from drug overdose, and one from complications of diabetes. CD45+ cells were present in the adventitia of the middle cerebral artery of subject 40; exclusively in the media of subject 29; exclusively in the intima of subject 2; in both the adventitia and media in subjects 10 and 12; in the adventitia, media, and intima of subject 27; and in the multiple arteries examined from subject 22, in the adventitia of the right vertebral artery; and in the adventitia, media, and intima of the left vertebral artery.
Discussion
Our analysis of 63 cerebral arteries from 45 subjects without symptoms or signs of stroke revealed no VZV or HSV-1 DNA or antigen. In addition, 13 % of arteries contained CD45+ leukocytes distributed throughout the adventitia, media, and intima. The subjects whose arteries contained CD45+ leukocytes were age 44 years or older, and there was no correlation with a particular disease or cause of death. While the significance of the occasional presence of inflammatory cells in normal cerebral arteries requires further study, the absence of Positive control VZV-infected cadaveric cerebral artery at 14 days post-infection contains VZV antigen (A, F; arrow, pink color; ×100 and ×600, respectively). No VZV antigen was detected in any of 63 arteries from 45 subjects (B and G show representative artery from subject 24; ×100 and ×600, respectively). Similarly, positive control HSV-1-infected cadaveric cerebral artery at 14 days post-infection shows HSV-1 antigen (C, H; arrow, pink color; ×100 and ×600, respectively), whereas none of the 63 arteries contained HSV-1 antigen (D and I show representative negative artery from subject 24; ×100 and ×600, respectively). Staining of arteries with normal rabbit serum (NRS) was negative (E, J; ×100 and ×600, respectively) A B C Fig. 2 Some normal human cerebral arteries contain CD45+ leukocytes. CD45 antigen is seen in positive control tonsils (a) and in eight cerebral arteries from seven subjects; (b) shows representative artery from subject 2; no staining was seen with normal rabbit serum (c). ×600
VZV DNA or antigen in normal subjects indicates that the presence of VZV antigen in cerebral arteries of patients with a history of transient ischemic attack or stroke is likely to be significant.
